Highbridge Capital Management’s Amryt Pharma AMYT Stock Holding History
Bought
Maintained
Sold
Highbridge Capital Management's AMYT Position: Q2 2023 in Review
Highbridge Capital Management sold out of Amryt Pharma (AMYT) in Q2 2023, closing a stake of 6,333,552 shares — an estimated $92.3M sold.
Highbridge Capital Management first reported a position in AMYT in Q3 2020 and held it in 11 quarters. The position peaked at $92.3M in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.
- Highbridge Capital Management reported no remaining Amryt Pharma position as of Q2 2023 after selling out during the quarter.
- Highbridge Capital Management sold 6,333,552 Amryt Pharma shares in Q2 2023, an estimated $92.3M.
- Highbridge Capital Management first reported a position in Amryt Pharma in Q3 2020 and held it in 11 quarters.
- Highbridge Capital Management's Amryt Pharma position peaked at $92.3M in Q1 2023.
- 0 funds tracked by Wall St. Rank held Amryt Pharma as of Q2 2023.
Based on Highbridge Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.